Christoph Wanner

4.8k total citations
22 papers, 1.1k citations indexed

About

Christoph Wanner is a scholar working on Nephrology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Christoph Wanner has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Nephrology, 11 papers in Surgery and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Christoph Wanner's work include Lipoproteins and Cardiovascular Health (10 papers), Chronic Kidney Disease and Diabetes (8 papers) and Dialysis and Renal Disease Management (4 papers). Christoph Wanner is often cited by papers focused on Lipoproteins and Cardiovascular Health (10 papers), Chronic Kidney Disease and Diabetes (8 papers) and Dialysis and Renal Disease Management (4 papers). Christoph Wanner collaborates with scholars based in Germany, United Kingdom and United States. Christoph Wanner's co-authors include Vera Krane, Bertram L. Kasiske, Eberhard Ritz, Peter W.F. Wilson, David C. Wheeler, Blanche M. Chavers, Richard H. Grimm, Adeera Levin, Rulan S. Parekh and Judith A. Beto and has published in prestigious journals such as The Lancet, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Christoph Wanner

19 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christoph Wanner Germany 13 453 372 197 187 168 22 1.1k
Margrét Árnadóttir Sweden 19 383 0.8× 562 1.5× 147 0.7× 100 0.5× 86 0.5× 40 1.4k
Jae Hyun Chang South Korea 22 851 1.9× 243 0.7× 122 0.6× 169 0.9× 129 0.8× 84 1.4k
Essam F. Elsayed United States 15 1.1k 2.3× 396 1.1× 177 0.9× 521 2.8× 229 1.4× 18 1.9k
Jung Nam An South Korea 21 519 1.1× 229 0.6× 120 0.6× 255 1.4× 48 0.3× 83 1.4k
Adrianne Ball United States 9 838 1.8× 344 0.9× 97 0.5× 189 1.0× 80 0.5× 12 1.4k
Gursharan Dogra Australia 22 551 1.2× 291 0.8× 228 1.2× 330 1.8× 38 0.2× 42 1.4k
Dimitrios Tsakiris United Kingdom 12 1.2k 2.6× 151 0.4× 106 0.5× 289 1.5× 59 0.4× 22 2.3k
Josef Zimmermann Germany 7 1.2k 2.7× 543 1.5× 115 0.6× 249 1.3× 92 0.5× 14 1.7k
Sören Madsen Denmark 12 329 0.7× 719 1.9× 200 1.0× 139 0.7× 55 0.3× 17 1.4k
Marcia Landa United States 7 781 1.7× 137 0.4× 245 1.2× 660 3.5× 128 0.8× 7 1.4k

Countries citing papers authored by Christoph Wanner

Since Specialization
Citations

This map shows the geographic impact of Christoph Wanner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Wanner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Wanner more than expected).

Fields of papers citing papers by Christoph Wanner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Wanner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Wanner. The network helps show where Christoph Wanner may publish in the future.

Co-authorship network of co-authors of Christoph Wanner

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Wanner. A scholar is included among the top collaborators of Christoph Wanner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Wanner. Christoph Wanner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Doreen, Parminder K. Judge, Christoph Wanner, Richard Haynes, & William G. Herrington. (2025). The prevention and management of chronic kidney disease among patients with metabolic syndrome. Kidney International. 107(5). 816–824. 6 indexed citations
2.
Herrington, William G., Parminder K. Judge, Morgan E. Grams, & Christoph Wanner. (2025). Chronic kidney disease. The Lancet. 407(10523). 90–104.
3.
Herrington, William G., Rebecca J. Sardell, Alistair Roddick, et al.. (2025). Effects of empagliflozin on conventional and exploratory acute and chronic kidney outcomes: an individual participant-level meta-analysis. The Lancet Diabetes & Endocrinology. 13(12). 1003–1014. 1 indexed citations
4.
Wanner, Christoph, Ming Zhao, Alpesh Amin, et al.. (2025). Guideline-Recommended Disease-Modifying Therapies for Patients with Cardiorenal Disease: A Call-to-Action Narrative Review. Advances in Therapy. 42(7). 3141–3157.
5.
Nicholas, Susanne B., Ricardo Correa-Rotter, Nihar R. Desai, et al.. (2024). First interim results from FINE-REAL: a prospective, non-interventional, phase 4 study providing insights into the use and safety of finerenone in a routine clinical setting. Journal of Nephrology. 37(8). 2223–2232. 9 indexed citations
6.
Tyl, Benoît, Pareen Vora, Alfredo E. Farjat, et al.. (2024). Association of a history of acute kidney injury with major adverse cardiovascular events in chronic kidney disease patients. European Heart Journal. 45(Supplement_1). 1 indexed citations
7.
Kalousová, Marta, Tomáš Zima, Vera Krane, et al.. (2014). Pregnancy-associated plasma protein A associates with cardiovascular events in diabetic hemodialysis patients. Atherosclerosis. 236(2). 263–269. 12 indexed citations
8.
Silbernagel, Günther, Iris Baumgärtner, Christoph Wanner, & Winfried März. (2014). Toward Individualized Cholesterol-Lowering Treatment in End-Stage Renal Disease. Journal of Renal Nutrition. 24(2). 65–71. 9 indexed citations
9.
Krane, Vera & Christoph Wanner. (2011). Statins, inflammation and kidney disease. Nature Reviews Nephrology. 7(7). 385–397. 69 indexed citations
10.
Drechsler, Christiane, Stefan Pilz, Marion Verduijn, et al.. (2010). Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. European Heart Journal. 31(18). 2253–2261. 201 indexed citations
11.
Rahimi, Kazem, Jonathan Emberson, Paul McGale, et al.. (2009). Effect of statins on atrial fibrillation: a collaborative meta-analysis of randomised controlled trials. Oxford University Research Archive (ORA) (University of Oxford). 13 indexed citations
12.
Kopple, Joel D., Alfred K. Cheung, Jens Sandahl Christiansen, et al.. (2008). OPPORTUNITY™. Clinical Journal of the American Society of Nephrology. 3(6). 1741–1751. 25 indexed citations
13.
Wanner, Christoph & Eberhard Ritz. (2008). Reducing lipids for CV protection in CKD patients—current evidence. Kidney International. 74(111). S24–S28. 13 indexed citations
14.
Ritz, Eberhard & Christoph Wanner. (2008). Lipid Abnormalities and Cardiovascular Risk in Renal Disease. Journal of the American Society of Nephrology. 19(6). 1065–1070. 34 indexed citations
15.
Kasiske, Bertram L., Christoph Wanner, & W. Charles O’Neill. (2006). An Assessment of Statin Safety by Nephrologists. The American Journal of Cardiology. 97(8). S82–S85. 47 indexed citations
16.
Krane, Vera & Christoph Wanner. (2005). Statine und Nephropathie. Der Diabetologe. 1(1). 20–25.
17.
18.
Locatelli, Francesco, Gérard M. London, Alejandro Martín‐Malo, et al.. (2001). Cardiovascular disease determinants in chronic renal failure: clinical approach and treatment. Nephrology Dialysis Transplantation. 16(3). 459–468. 103 indexed citations
19.
Galle, Jan, Alexandra N. Heinloth, Christoph Wanner, & Kathrin Heermeier. (2001). Dual effect of oxidized LDL on cell cycle in human endothelial cells through oxidative stress. Kidney International. 59. S120–S123. 47 indexed citations
20.
Wanner, Christoph, Walter H. Hörl, Claus Luley, & Heinrich Wieland. (1991). Effects of HMG-CoA reductase inhibitors in hypercholesterolemic patients on hemodialysis. Kidney International. 39(4). 754–760. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margrét Árnadóttir Breakdown of academic impact, for papers by Jae Hyun Chang Breakdown of academic impact, for papers by Essam F. Elsayed Breakdown of academic impact, for papers by Jung Nam An Breakdown of academic impact, for papers by Adrianne Ball Breakdown of academic impact, for papers by Gursharan Dogra Breakdown of academic impact, for papers by Dimitrios Tsakiris Breakdown of academic impact, for papers by Josef Zimmermann Breakdown of academic impact, for papers by Sören Madsen Breakdown of academic impact, for papers by Marcia Landa
Rankless by CCL
2026